Chambers Review
Provided by Chambers
Chambers Greater China Region
Competition/Antitrust: Foreign Legal Consultants (PRC Firms) - China
Individual Editorial
领先律师
许蓉蓉律师凭借其竞争业务而受到尊重,并协助客户进行国际合并审查和申报。她的反垄断业务受益于她的公司并购的专业背景及其在香港的市场里的位置。

Email address
[email protected]Contact number
86 10 8519 1280Share profile
Band 1
Provided by Janet Hui
Janet Hui is a partner at JunHe LLP and is based in Beijing. She primarily specializes in antitrust, cross-border M&A, FDI and general corporate matters. Janet has been recognized as a Band 1 Ranked Lawyer by Chambers and Partners (Asia-Pacific 2012-2024), Leading Lawyer and Recommended Lawyer by The Legal 500 (2012-2024), Highly Regarded Lawyer by IFLR1000 (2017-2024), and Thought Leader- Global Elite by Who’s Who Legal (2017-2024) in antitrust matters. Janet is the Co-Chair of IBA Antitrust Committee from 2023 to 2024 and ex-Co-Chair of IPBA Competition Committee.
Janet has more than 30 years’ experience in providing legal services to clients in different industries, particularly in areas such as telecommunications and media, hotels and real estate, aviation, automobile, semiconductor, pharmaceutical, medical instrument, food and beverage, etc.
Janet has extensive experience in handling cross border M&A transactions including advising on viable structure for complex transactions, identifying and resolving legal and regulatory issues, drafting, revising and finalizing transaction documents and attending to closing and post-closing material matters.
Janet also has substantial experience in handling various competition and antitrust work including:
• applying for clearances for complicated merger control filings, filing complaints against transactions under merger control review;
• handling investigations for failure to file and transactions with competition concerns or issues;
• reviewing and advising on whether transactions and/or commercial arrangement may have competition concerns or issues and solutions to resolve these concerns or issues;
• defending antitrust investigations on alleged anti-competitive practices in China;
• applying for leniency for certain infringement actions under the Anti-Monopoly Law; and
• providing compliance advice and training to multinational companies in different industries.
Member of the Law Society of Hong Kong.
Greater Bay Area Chinese Bar Exam, 2022.
Solicitor and Barrister of New Zealand, 1996.
Solicitor of England and Wales, 1994.
Solicitor of Hong Kong, 1990.
Provided by Chambers
许蓉蓉律师凭借其竞争业务而受到尊重,并协助客户进行国际合并审查和申报。她的反垄断业务受益于她的公司并购的专业背景及其在香港的市场里的位置。
Provided by Chambers
She knows the laws and regulations and industry peculiarities and has deep, practical insight.
She understands how American-led businesses work and what their issues are in China, and she also understands the work of regulators in China.
她了解美国企业在中国的运作模式和面临的挑战,也了解中国监管机构的工作。
她了解法律法规和行业特点,并具有深刻的实践洞察力。
She knows the laws and regulations and industry peculiarities and has deep, practical insight.
She understands how American-led businesses work and what their issues are in China, and she also understands the work of regulators in China.
她了解美国企业在中国的运作模式和面临的挑战,也了解中国监管机构的工作。
她了解法律法规和行业特点,并具有深刻的实践洞察力。
7 items provided by JunHe LLP
JunHe Assisted INEOS in Three Major Deals with Sinopec Worth USD 7 billion
On 28 July 2022, INEOS ("INEOS") and China Petroleum & Chemical Corporation ("Sinopec"; Stock Code: 600028.SH, 00386.HK) entered into a series of acquisition and joint venture cooperation agreements with respect to three major transactions.
JunHe Assisted INEOS in Three Major Deals with Sinopec Worth USD 7 billion
On 28 July 2022, INEOS ("INEOS") and China Petroleum & Chemical Corporation ("Sinopec"; Stock Code: 600028.SH, 00386.HK) entered into a series of acquisition and joint venture cooperation agreements with respect to three major transactions.
JunHe advises Grifols in the sale of a 20% equity stake in SRAAS and its strategic alliance with Hai
On June 18, 2024, Grifols, S.A. ("Grifols"), a global healthcare company and a leading producer of plasma-derived medicines, announced completion of the sale of a 20% equity stake in Shanghai RAAS (“SRAAS”) to Haier Group Corporation (“Haier Group”) for RMB 12.5 billion (approximately USD 1.8 billio
JunHe wins GCR's award for the fourth time
JunHe recently won Global Competition Review’s award “Merger Control Matter of the Year-Asia-Pacific, Middle East and Africa” for Broadcom's acquisition of VMware. JunHe advised VMware in the project, and the JunHe team was led by partners Janet Hui and GONG, Mingfang and consultant WANG, Dongxin.
JunHe Advises Carlyle on the Sale of its Entire Stake in McDonald’s China Business
In Nov. 2023, The Carlyle Group said McDonald's would buy its 28% stake in the China region partnership. The deal closed in Jan. 2024, raising McDonald's stake to 48%. JunHe was Carlyle's sole PRC legal counsel.
JunHe Assists JX Metal in its Acquisition of the Equity Interests in Tatsuta Electric Wire & Cable
On 11 June 2024, the State Administration of Market Regulation (“SAMR”) issued a notice of antitrust review and approved the acquisition by JX Metals Corporation ("JX Metal") of the equity interests in Tatsuta Electric Wire & Cable Co., Ltd.(“Tatsuta”).
JunHe guides Grifols in SRAAS equity sale and Haier alliance
On June 18, 2024, Grifols sold a 20% stake in SRAAS to Haier Group for RMB 12.5 billion, retaining a 6.58% stake and forming a strategic alliance with Haier and SRAAS. (Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group).
JunHe Assisted INEOS in Three Major Deals with Sinopec Worth USD 7 billion
On 28 July 2022, INEOS ("INEOS") and China Petroleum & Chemical Corporation ("Sinopec"; Stock Code: 600028.SH, 00386.HK) entered into a series of acquisition and joint venture cooperation agreements with respect to three major transactions.
JunHe Assisted INEOS in Three Major Deals with Sinopec Worth USD 7 billion
On 28 July 2022, INEOS ("INEOS") and China Petroleum & Chemical Corporation ("Sinopec"; Stock Code: 600028.SH, 00386.HK) entered into a series of acquisition and joint venture cooperation agreements with respect to three major transactions.
JunHe advises Grifols in the sale of a 20% equity stake in SRAAS and its strategic alliance with Hai
On June 18, 2024, Grifols, S.A. ("Grifols"), a global healthcare company and a leading producer of plasma-derived medicines, announced completion of the sale of a 20% equity stake in Shanghai RAAS (“SRAAS”) to Haier Group Corporation (“Haier Group”) for RMB 12.5 billion (approximately USD 1.8 billio
JunHe wins GCR's award for the fourth time
JunHe recently won Global Competition Review’s award “Merger Control Matter of the Year-Asia-Pacific, Middle East and Africa” for Broadcom's acquisition of VMware. JunHe advised VMware in the project, and the JunHe team was led by partners Janet Hui and GONG, Mingfang and consultant WANG, Dongxin.
JunHe Advises Carlyle on the Sale of its Entire Stake in McDonald’s China Business
In Nov. 2023, The Carlyle Group said McDonald's would buy its 28% stake in the China region partnership. The deal closed in Jan. 2024, raising McDonald's stake to 48%. JunHe was Carlyle's sole PRC legal counsel.
JunHe Assists JX Metal in its Acquisition of the Equity Interests in Tatsuta Electric Wire & Cable
On 11 June 2024, the State Administration of Market Regulation (“SAMR”) issued a notice of antitrust review and approved the acquisition by JX Metals Corporation ("JX Metal") of the equity interests in Tatsuta Electric Wire & Cable Co., Ltd.(“Tatsuta”).
JunHe guides Grifols in SRAAS equity sale and Haier alliance
On June 18, 2024, Grifols sold a 20% stake in SRAAS to Haier Group for RMB 12.5 billion, retaining a 6.58% stake and forming a strategic alliance with Haier and SRAAS. (Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group).